<result><BiopanningDataSet><Item><BiopanningDataSetID>1876</BiopanningDataSetID>
<Peptides>CISTHGPLC(1.0)</Peptides>
<Motif></Motif>
<Unique_Sequence_Number>1</Unique_Sequence_Number>
<Experimental_Method>Phage display (subtractive panning)</Experimental_Method>
<Rounds_of_Panning>10</Rounds_of_Panning>
<Reference>PMID:22002548</Reference>
<Target_Name>Hsp70-peptide complexes, Hsp70-PCs</Target_Name>
<Template_Name>Not determined.</Template_Name>
<Structure_of_Target_Template_Complex>Not determined.</Structure_of_Target_Template_Complex>
<Structure_of_Target_Peptide_Complex>Not determined.</Structure_of_Target_Peptide_Complex>
<Library_Name>Ph.D.-C7C phage display library (CX7C)</Library_Name>
<Affinity_Measurement_Method></Affinity_Measurement_Method>
<Affinity_Measurement_Description></Affinity_Measurement_Description>
<Brief_Description>Hsp70-PCs were obtained from the human breast carcinoma cell line MDA-MB-231 using ADP-agarose affinity chromatography. Phages interacting with the HSP70 moiety of the HSP70-PC were removed using a subtractive biopanning step with recombinant HSP70.</Brief_Description>
<BiopanningDataSet_Comments>One of the peptides (ISTHGPL), termed IST, enriched in the biopanning process, was used in a \'pull-down\' assay to identify the original protein from which the HSP70-associated peptides may have been derived. The eukaryotic translation initiation factor 3 (eIF-3), a member of the elongation factor EF1α family, and the HSP GRP78, were pulled down by theIST peptide. All of these proteins are known to be up-regulated in cancer cells. Immunohistochemical staining of tumour tissue microarrays showed that the peptide co-localised with HSP70 in breast tumour tissue.</BiopanningDataSet_Comments>
</Item><Item><BiopanningDataSetID>1877</BiopanningDataSetID>
<Peptides>STLNVLQ(0.50)
TQKWPPH(0.17)
HPLIHPD(0.17)
APNETRS(0.17)</Peptides>
<Motif></Motif>
<Unique_Sequence_Number>1</Unique_Sequence_Number>
<Experimental_Method>Phage display (subtractive panning)</Experimental_Method>
<Rounds_of_Panning>10</Rounds_of_Panning>
<Reference>PMID:22002548</Reference>
<Target_Name>Hsp70-peptide complexes, Hsp70-PCs</Target_Name>
<Template_Name>Not determined.</Template_Name>
<Structure_of_Target_Template_Complex>Not determined.</Structure_of_Target_Template_Complex>
<Structure_of_Target_Peptide_Complex>Not determined.</Structure_of_Target_Peptide_Complex>
<Library_Name>Ph.D.-C7C phage display library (CX7C)</Library_Name>
<Affinity_Measurement_Method></Affinity_Measurement_Method>
<Affinity_Measurement_Description></Affinity_Measurement_Description>
<Brief_Description>Hsp70-PCs were obtained from the human breast carcinoma cell line MCF-7 using ADP-agarose affinity chromatography. Phages interacting with the HSP70 moiety of the HSP70-PC were removed using a subtractive biopanning step with recombinant HSP70.</Brief_Description>
<BiopanningDataSet_Comments></BiopanningDataSet_Comments>
</Item><Item><BiopanningDataSetID>1878</BiopanningDataSetID>
<Peptides>WHWRNPDFWYLK(10)[0.83]
SNNLYPQRAVST(1)[0.07]
LETEWDSLWYAP(1)[0.11]</Peptides>
<Motif></Motif>
<Unique_Sequence_Number>3</Unique_Sequence_Number>
<Experimental_Method>Phage display (common panning)</Experimental_Method>
<Rounds_of_Panning>5</Rounds_of_Panning>
<Reference>PMID:22003385</Reference>
<Target_Name>Alanine aminotransferase 1, ALT1</Target_Name>
<Template_Name>Not determined.</Template_Name>
<Structure_of_Target_Template_Complex>Not determined.</Structure_of_Target_Template_Complex>
<Structure_of_Target_Peptide_Complex>Not determined.</Structure_of_Target_Peptide_Complex>
<Library_Name>Ph.D.-12 phage display library (X12)</Library_Name>
<Affinity_Measurement_Method>ELISA,Quartz crystal microbalance (QCM)</Affinity_Measurement_Method>
<Affinity_Measurement_Description>In phage ELISA, ALT binding of the selected phage clones and M13 control phage incubated with varying concentrations of phage particles ranging from e5 pfu to e11 pfu. All measurements were performed in triplicate. The absorbance at 490 nm was reproduced and shown as means of three measurements when the concentration of phage particles is e11 pfu. The absorbance of M13 control phage is 0.07. Besides the apparent dissociation constant (Kd,app, nM) for the ALT5-8 clone with the sequence of WHWRNPDFWYLK is determined by further ELISA experiments. Further, the inhibition constant for the ALT5-8 peptide was found to be KI=71 ± 17 nM. A dissociation constant of Kd= 2.01 ± 0.06 mg/mL or 20.1 ± 0.6 nM was calculated for ALT binding on QCM.</Affinity_Measurement_Description>
<Brief_Description></Brief_Description>
<BiopanningDataSet_Comments>Phage particles expressing this peptide exhibited nanomolar affinity for immobilized ALT (Kd,app = 85±20 nM).</BiopanningDataSet_Comments>
</Item><Item><BiopanningDataSetID>1879</BiopanningDataSetID>
<Peptides>LTTKQHNALPRG[0.217]
HENPKWHTTPVL[0.243]
HMNPKDLVMNSP[0.230]
YVVPQSPVRADS[0.321]
EHTMAGWWHPSK[0.217]
LSPRPLWDAWEQ[NT]
SMPSPSYLFGYL[NT]
SWSIVPTSPIIL[NT]
MNVTVSGRLSGP[NT]
TWDLRIHRSVHG[NT]
SLPDLRHWSASK[NT]
TLSVNSNYGAFT[NT]
HENPKQNPLTAR[NT]
HANPKQNNHTTS[NT]
NPKHIGAEVPQR[NT]
YGLNPKWATLKY[NT]
SDRISGTSPTRL[NT]
IFASFRTSPDQS[NT]
HESPKPTVWQTK[NT]</Peptides>
<Motif></Motif>
<Unique_Sequence_Number>19</Unique_Sequence_Number>
<Experimental_Method>Phage display (common panning)</Experimental_Method>
<Rounds_of_Panning>3</Rounds_of_Panning>
<Reference>PMID:22015270</Reference>
<Target_Name>Anti-SP1 polyclonal antibody IgGs</Target_Name>
<Template_Name>Peptide SP1 (LDLERDARVRAERNANEMSI) of Paramyosin</Template_Name>
<Structure_of_Target_Template_Complex>Not determined.</Structure_of_Target_Template_Complex>
<Structure_of_Target_Peptide_Complex>Not determined.</Structure_of_Target_Peptide_Complex>
<Library_Name>Ph.D.-12 phage display library (X12)</Library_Name>
<Affinity_Measurement_Method>ELISA</Affinity_Measurement_Method>
<Affinity_Measurement_Description>Reactivity of anti-SP2 IgG and anti-SP-1 IgG with their selected  mimotopes was measured by ELISA. Optical densities at 405 nm were determined, reproduced from the graph and expressed as mean ± SD. The O.D. obtained using an irrelevant phage was 0.064. NT denotes not tested.</Affinity_Measurement_Description>
<Brief_Description></Brief_Description>
<BiopanningDataSet_Comments>Antibodies to α-helical regions SP1 were weak binders and M13 phage-displayed peptides selected by them from two different libraries exhibited no amino-acid similarities with the original protein site.</BiopanningDataSet_Comments>
</Item><Item><BiopanningDataSetID>1880</BiopanningDataSetID>
<Peptides>CSLGSQNGC[0.141]
CIGPGDRQC[NT]
CLAPGDQGC[NT]
CLRNALNEC[NT]
CNHLHSQRC[NT]
CDTRITKRC[NT]
CNSWLSHRC[NT]
CQHLSSSSC[NT]
CSAQSLTLC[NT]
CMDPNLPNC[NT]
CIDPNRPNC[NT]
CKDPNLKNC[NT]
CNPKHPLHC[NT]
CWQTPSPQC[NT]</Peptides>
<Motif></Motif>
<Unique_Sequence_Number>14</Unique_Sequence_Number>
<Experimental_Method>Phage display (common panning)</Experimental_Method>
<Rounds_of_Panning>3</Rounds_of_Panning>
<Reference>PMID:22015270</Reference>
<Target_Name>Anti-SP1 polyclonal antibody IgGs</Target_Name>
<Template_Name>Peptide SP1 (LDLERDARVRAERNANEMSI) of Paramyosin</Template_Name>
<Structure_of_Target_Template_Complex>Not determined.</Structure_of_Target_Template_Complex>
<Structure_of_Target_Peptide_Complex>Not determined.</Structure_of_Target_Peptide_Complex>
<Library_Name>Ph.D.-C7C phage display library (CX7C)</Library_Name>
<Affinity_Measurement_Method>ELISA</Affinity_Measurement_Method>
<Affinity_Measurement_Description>Reactivity of anti-SP2 IgG and anti-SP-1 IgG with their selected  mimotopes was measured by ELISA. Optical densities at 405 nm were determined, reproduced from the graph and expressed as mean ± SD. The O.D. obtained using an irrelevant phage was 0.064. NT denotes not tested.</Affinity_Measurement_Description>
<Brief_Description></Brief_Description>
<BiopanningDataSet_Comments>Antibodies to α-helical regions SP1 were weak binders and M13 phage-displayed peptides selected by them from two different libraries exhibited no amino-acid similarities with the original protein site.</BiopanningDataSet_Comments>
</Item><Item><BiopanningDataSetID>1881</BiopanningDataSetID>
<Peptides>DQLLSGSTPWSF[1.098 ± 0.249]
AQTLSGTLASHT[1.006 ± 0.046]
TTQVLSGTLPQH[1.131 ± 0.117]
LHMPPQMLSGTI[0.589 ± 0.109]
SQMQILSGSHLA[1.365 ± 0.333]
HDQVLSGIKWPH[1.297 ± 0.081]
DHSHSNTSGPWV[NT]
APEHSQLRHMDP[NT]
TIHQVLSATTSH[NT]
SVGQTLSGSMLF[NT]
QTQMLSGTLIPQ[NT]
GQMLSGSNMQLP[NT]
MPQILSASRLYA[NT]
VPFLPQILSGSL[NT]
SLQQLLSGTWLG[NT]
SAVLTDIHPVLPNT[NT]
KHQVYLRSDLPFNT[NT]
SNWRDPLPQTEGNT[NT]</Peptides>
<Motif>Q-x-LSGST</Motif>
<Unique_Sequence_Number>18</Unique_Sequence_Number>
<Experimental_Method>Phage display (common panning)</Experimental_Method>
<Rounds_of_Panning>3</Rounds_of_Panning>
<Reference>PMID:22015270</Reference>
<Target_Name>Anti-SP2 polyclonal antibody IgGs</Target_Name>
<Template_Name>Peptide SP2 (LDELSGTSSQTHDAIRRKDME) of Paramyosin</Template_Name>
<Structure_of_Target_Template_Complex>Not determined.</Structure_of_Target_Template_Complex>
<Structure_of_Target_Peptide_Complex>Not determined.</Structure_of_Target_Peptide_Complex>
<Library_Name>Ph.D.-12 phage display library (X12)</Library_Name>
<Affinity_Measurement_Method>ELISA</Affinity_Measurement_Method>
<Affinity_Measurement_Description>Reactivity of anti-SP2 IgG and anti-SP-1 IgG with their selected  mimotopes was measured by ELISA. Optical densities at 405 nm were determined, reproduced from the graph and expressed as mean ± SD. The O.D. obtained using an irrelevant phage was 0.064. NT denotes not tested.</Affinity_Measurement_Description>
<Brief_Description></Brief_Description>
<BiopanningDataSet_Comments>Antibodies produced in response to non-helical segment within α-helical structure were better binders and selectors of perfect structural mimics of the protein site.</BiopanningDataSet_Comments>
</Item><Item><BiopanningDataSetID>1882</BiopanningDataSetID>
<Peptides>CQQLSRNHC[0.600 ± 0.015]
CFQVLSRSC[0.370 ± 0.102]
CQRLSGPYC[0.767 ± 0.008]
CQKLSQAAC[0.561 ± 0.041]
CTQRTQAIC[NT]
CPARDQKLC[NT]
CTVSLRHVC[NT]
CPIQHLSQC[NT]
CKTSLKTLC[NT]
CQHLSTPVC[NT]
CEQTLSGQC[NT]
CQTLSKAHC[NT]
CQSLSQKLC[NT]
CQSLSRPLC[NT]
CQSLSFNLC[NT]
CQSLSVPRC[NT]
CQRLSNNYC[NT]
CQKLSANMC[NT]
CQKLSMPVC[NT]
CQRLSFPIC[NT]
CQRLSLPSC[NT]
CQKLSLPTC[NT]
CQKLSMPAC[NT]
CQRLSLAAC[NT]
CQRLSTQLC[NT]
CQRLSTAHC[NT]
CNQQLSRSC[NT]
CTQHLSRSC[NT]
CPAKNPSAC[NT]
CDNTSPSEC[NT]
CKYTPQPSC[NT]
CNASPQFAC[NT]</Peptides>
<Motif>Q-x-LSGST</Motif>
<Unique_Sequence_Number>32</Unique_Sequence_Number>
<Experimental_Method>Phage display (common panning)</Experimental_Method>
<Rounds_of_Panning>3</Rounds_of_Panning>
<Reference>PMID:22015270</Reference>
<Target_Name>Anti-SP2 polyclonal antibody IgGs</Target_Name>
<Template_Name>Peptide SP2 (LDELSGTSSQTHDAIRRKDME) of Paramyosin</Template_Name>
<Structure_of_Target_Template_Complex>Not determined.</Structure_of_Target_Template_Complex>
<Structure_of_Target_Peptide_Complex>Not determined.</Structure_of_Target_Peptide_Complex>
<Library_Name>Ph.D.-C7C phage display library (CX7C)</Library_Name>
<Affinity_Measurement_Method>ELISA</Affinity_Measurement_Method>
<Affinity_Measurement_Description>Reactivity of anti-SP2 IgG and anti-SP-1 IgG with their selected  mimotopes was measured by ELISA. Optical densities at 405 nm were determined, reproduced from the graph and expressed as mean ± SD. The O.D. obtained using an irrelevant phage was 0.064. NT denotes not tested.</Affinity_Measurement_Description>
<Brief_Description></Brief_Description>
<BiopanningDataSet_Comments>Antibodies produced in response to non-helical segment within α-helical structure were better binders and selectors of perfect structural mimics of the protein site.</BiopanningDataSet_Comments>
</Item><Item><BiopanningDataSetID>1883</BiopanningDataSetID>
<Peptides>QPFTTSLTPPAR(3)[0.416 ± 0.011]
LKGPMTDVRESA(2)[0.225 ± 0.002]
APLPYDHHSAGS(1)[0.292 ± 0.014]
HHQNPPLFLGTS(1)[0.220 ± 0.004]
ASLTDRPTLTPV(1)[0.244 ± 0.010]
SLNETQHFAFHH(1)[0.264 ± 0.028]
TVYSMNSAAPRP(1)[0.272 ± 0.019]
SAHGTSTGVPWP(1)[0.204 ± 0.003]
NNWSSPPQMISR(1)[0.357 ± 0.017]
NFSQPPSKHTRS(1)[0.293 ± 0.010]
ATFSPPQQSLMM(1)[0.349 ± 0.019]
NSIQALDSTNGQ(1)[0.225 ± 0.022]
HPLFHHQTATAT(1)[0.234 ± 0.010]
ISTSPPQGSTSS(1)[0.294 ± 0.013]</Peptides>
<Motif></Motif>
<Unique_Sequence_Number>14</Unique_Sequence_Number>
<Experimental_Method>Phage display (competitive panning)</Experimental_Method>
<Rounds_of_Panning>3</Rounds_of_Panning>
<Reference>PMID:22033953</Reference>
<Target_Name>Mouse cardiomyocyte</Target_Name>
<Template_Name>Not determined.</Template_Name>
<Structure_of_Target_Template_Complex>Not determined.</Structure_of_Target_Template_Complex>
<Structure_of_Target_Peptide_Complex>Not determined.</Structure_of_Target_Peptide_Complex>
<Library_Name>Ph.D.-12 phage display library (X12)</Library_Name>
<Affinity_Measurement_Method>ELISA</Affinity_Measurement_Method>
<Affinity_Measurement_Description>Reactivity of anti-SP2 IgG and anti-SP-1 IgG with their selected  mimotopes was measured by ELISA. Optical densities at 405 nm were determined, reproduced from the graph and expressed as mean ± SD. The O.D. obtained using an irrelevant phage was 0.064. NT denotes not tested.</Affinity_Measurement_Description>
<Brief_Description>The areas with induced beating cardiomyocytes were selected and trypsinized into single cells for the positive screen; undifferentiated  mouse embryonic stem cells (mESC) were used as the negative screen.</Brief_Description>
<BiopanningDataSet_Comments>The ELISA results show the no. 3 sequence peptide (QPFTTSLTPPAR), and other four sequences having a consensus motif [SS(Q)PPQ(S)], no. 9, 11, 14, and 10, have relatively high affinity and specificity to cardiomyocytes. Immunofluorescence confirmed that the selected peptides could bind specifically to the PSC-derived cardiomyocytes. Competition tests with chemically synthesized peptides revealed the binding ability was caused by the peptide itself. Western blot analysis proved the phages were both bound to two 17 kDa cardiomyocyte membrane proteins and the no. 9 sequence showed a 55 kDa protein that was not observed in the no. 3 sequence. These results suggest that the selected peptides specifically target receptors on PSC-derived cardiomyocyte membranes.</BiopanningDataSet_Comments>
</Item><Item><BiopanningDataSetID>1884</BiopanningDataSetID>
<Peptides>CRPPR
CRKDKC
KSTRKS
CARSKNKDC</Peptides>
<Motif></Motif>
<Unique_Sequence_Number>4</Unique_Sequence_Number>
<Experimental_Method>Phage display (in vivo)</Experimental_Method>
<Rounds_of_Panning></Rounds_of_Panning>
<Reference>PMID:22047107</Reference>
<Target_Name>Mouse mesenchymal stem cells</Target_Name>
<Template_Name>Not determined.</Template_Name>
<Structure_of_Target_Template_Complex>Not determined.</Structure_of_Target_Template_Complex>
<Structure_of_Target_Peptide_Complex>Not determined.</Structure_of_Target_Peptide_Complex>
<Library_Name>fUSE5 phage display library</Library_Name>
<Affinity_Measurement_Method></Affinity_Measurement_Method>
<Affinity_Measurement_Description></Affinity_Measurement_Description>
<Brief_Description></Brief_Description>
<BiopanningDataSet_Comments>Cell coating was optimized and coating persistence and cytotoxicity were evaluated. MSCs were coated with peptides, injected into mice with MI, and MSCs in the heart quantified. Greater numbers of MSCs were found in heart of animals treated with the peptide-coated MSCs compared to uncoated controls. MSC numbers had positive correlation with MI severity in peptide-coated cells but a negative correlation in MSCs alone. A transient cell coating (&quot;painting&quot;) method has been developed that labels cells efficiently, non-toxically and increases cell localization in MI heart.</BiopanningDataSet_Comments>
</Item><Item><BiopanningDataSetID>1885</BiopanningDataSetID>
<Peptides>HFFKWHTRTNDQ
HMFKWHTRTNDQ
HYFKWHTRTNDQ</Peptides>
<Motif>TRVTND</Motif>
<Unique_Sequence_Number>3</Unique_Sequence_Number>
<Experimental_Method>Phage display (common panning)</Experimental_Method>
<Rounds_of_Panning>3</Rounds_of_Panning>
<Reference>PMID:22048717</Reference>
<Target_Name>Anti-CYR61 monoclonal antibody 096B7</Target_Name>
<Template_Name>Protein CYR61</Template_Name>
<Structure_of_Target_Template_Complex>Not determined.</Structure_of_Target_Template_Complex>
<Structure_of_Target_Peptide_Complex>Not determined.</Structure_of_Target_Peptide_Complex>
<Library_Name>Ph.D.-12 phage display library (X12)</Library_Name>
<Affinity_Measurement_Method></Affinity_Measurement_Method>
<Affinity_Measurement_Description></Affinity_Measurement_Description>
<Brief_Description></Brief_Description>
<BiopanningDataSet_Comments></BiopanningDataSet_Comments>
</Item><Item><BiopanningDataSetID>1886</BiopanningDataSetID>
<Peptides>CLANFTPHC
CLFNFDPTC
CLKNWNPHC
CLLNCNPQC
CLLNFSPYC
CLLNWDPQC
CLLNWNPHC
CLLNWTPHC
CLMNWTPHC
CLPNWNPHC
CLPNWTPQC</Peptides>
<Motif>L-[PL]-N-[WFC]-[NTL]-P-[HQT]</Motif>
<Unique_Sequence_Number>11</Unique_Sequence_Number>
<Experimental_Method>Phage display (common panning)</Experimental_Method>
<Rounds_of_Panning>3</Rounds_of_Panning>
<Reference>PMID:22048717</Reference>
<Target_Name>Anti-CYR61 monoclonal antibody 093G9</Target_Name>
<Template_Name>Protein CYR61</Template_Name>
<Structure_of_Target_Template_Complex>Not determined.</Structure_of_Target_Template_Complex>
<Structure_of_Target_Peptide_Complex>Not determined.</Structure_of_Target_Peptide_Complex>
<Library_Name>Ph.D.-C7C phage display library (CX7C)</Library_Name>
<Affinity_Measurement_Method></Affinity_Measurement_Method>
<Affinity_Measurement_Description></Affinity_Measurement_Description>
<Brief_Description></Brief_Description>
<BiopanningDataSet_Comments></BiopanningDataSet_Comments>
</Item><Item><BiopanningDataSetID>1887</BiopanningDataSetID>
<Peptides>QQPPMHLMSYAG</Peptides>
<Motif></Motif>
<Unique_Sequence_Number>1</Unique_Sequence_Number>
<Experimental_Method>Phage display (subtractive panning)</Experimental_Method>
<Rounds_of_Panning>3</Rounds_of_Panning>
<Reference>PMID:22071019</Reference>
<Target_Name>Human renal carcinoma cell line A498</Target_Name>
<Template_Name>Not determined.</Template_Name>
<Structure_of_Target_Template_Complex>Not determined.</Structure_of_Target_Template_Complex>
<Structure_of_Target_Peptide_Complex>Not determined.</Structure_of_Target_Peptide_Complex>
<Library_Name>Ph.D.-12 phage display library (X12)</Library_Name>
<Affinity_Measurement_Method></Affinity_Measurement_Method>
<Affinity_Measurement_Description></Affinity_Measurement_Description>
<Brief_Description>A normal renal cell line HK-2 were used to carry out subtractive screening in vitro.</Brief_Description>
<BiopanningDataSet_Comments>Through a cell-based ELISA, immunocytochemical staining, immunohistochemical staining, and immunofluorescence, the Phage ZT-2 and synthetic peptide ZT-2 were shown to specifically bind to the tumor cell surfaces of A498 and incision specimens, but not to normal renal tissue samples.</BiopanningDataSet_Comments>
</Item><Item><BiopanningDataSetID>1888</BiopanningDataSetID>
<Peptides>ASLRTLTSLLPA
NFMESLPRLGMH
AHLELRSNNMYF</Peptides>
<Motif></Motif>
<Unique_Sequence_Number>3</Unique_Sequence_Number>
<Experimental_Method>Phage display (common panning)</Experimental_Method>
<Rounds_of_Panning>3</Rounds_of_Panning>
<Reference>PMID:22065589</Reference>
<Target_Name>Caspase recruitment domain (CARD) of APAF-1</Target_Name>
<Template_Name>Not determined.</Template_Name>
<Structure_of_Target_Template_Complex>Not determined.</Structure_of_Target_Template_Complex>
<Structure_of_Target_Peptide_Complex>Not determined.</Structure_of_Target_Peptide_Complex>
<Library_Name>Ph.D.-12 phage display library (X12)</Library_Name>
<Affinity_Measurement_Method></Affinity_Measurement_Method>
<Affinity_Measurement_Description></Affinity_Measurement_Description>
<Brief_Description></Brief_Description>
<BiopanningDataSet_Comments></BiopanningDataSet_Comments>
</Item><Item><BiopanningDataSetID>1889</BiopanningDataSetID>
<Peptides>WPTPPYA</Peptides>
<Motif></Motif>
<Unique_Sequence_Number>1</Unique_Sequence_Number>
<Experimental_Method>Phage display (common panning)</Experimental_Method>
<Rounds_of_Panning>3</Rounds_of_Panning>
<Reference>PMID:22065589</Reference>
<Target_Name>Caspase recruitment domain (CARD) of APAF-1</Target_Name>
<Template_Name>Not determined.</Template_Name>
<Structure_of_Target_Template_Complex>Not determined.</Structure_of_Target_Template_Complex>
<Structure_of_Target_Peptide_Complex>Not determined.</Structure_of_Target_Peptide_Complex>
<Library_Name>Ph.D.-7 phage display library (X7)</Library_Name>
<Affinity_Measurement_Method></Affinity_Measurement_Method>
<Affinity_Measurement_Description></Affinity_Measurement_Description>
<Brief_Description></Brief_Description>
<BiopanningDataSet_Comments></BiopanningDataSet_Comments>
</Item><Item><BiopanningDataSetID>1890</BiopanningDataSetID>
<Peptides>CSWFEASYC
CLPTLHLLC</Peptides>
<Motif></Motif>
<Unique_Sequence_Number>2</Unique_Sequence_Number>
<Experimental_Method>Phage display (common panning)</Experimental_Method>
<Rounds_of_Panning>3</Rounds_of_Panning>
<Reference>PMID:22065589</Reference>
<Target_Name>Caspase recruitment domain (CARD) of APAF-1</Target_Name>
<Template_Name>Not determined.</Template_Name>
<Structure_of_Target_Template_Complex>Not determined.</Structure_of_Target_Template_Complex>
<Structure_of_Target_Peptide_Complex>Not determined.</Structure_of_Target_Peptide_Complex>
<Library_Name>Ph.D.-C7C phage display library (CX7C)</Library_Name>
<Affinity_Measurement_Method></Affinity_Measurement_Method>
<Affinity_Measurement_Description></Affinity_Measurement_Description>
<Brief_Description></Brief_Description>
<BiopanningDataSet_Comments></BiopanningDataSet_Comments>
</Item><Item><BiopanningDataSetID>1891</BiopanningDataSetID>
<Peptides>RGWCRPLPKGEG(14)</Peptides>
<Motif></Motif>
<Unique_Sequence_Number>1</Unique_Sequence_Number>
<Experimental_Method>Phage display (subtractive panning)</Experimental_Method>
<Rounds_of_Panning>3</Rounds_of_Panning>
<Reference>PMID:22086793</Reference>
<Target_Name>Sera from early-stage primary HCC patients</Target_Name>
<Template_Name>Not determined.</Template_Name>
<Structure_of_Target_Template_Complex>Not determined.</Structure_of_Target_Template_Complex>
<Structure_of_Target_Peptide_Complex>Not determined.</Structure_of_Target_Peptide_Complex>
<Library_Name>Ph.D.-12 phage display library (X12)</Library_Name>
<Affinity_Measurement_Method></Affinity_Measurement_Method>
<Affinity_Measurement_Description></Affinity_Measurement_Description>
<Brief_Description>Microtiter wells were respectively coated overnight with 100ml of purified IgG (100μμg/ml) from each of the control groups. The plates were blocked with 3% nonfat milk for 2 hr, and then washed five times with 0.05% Tween-20 in Tris-buffered saline (PBST). One hundred ?`l of diluted random 12-peptide phage display library with a titer of 1.5e11 pfu/ml was added to coated plates. After sequential incubation for 1 hr at room temperature with each of the control IgG-coated plates, the unbound phages were collected and added 100μl/well into the early HCC-IgG-coated plate. Another two rounds of affinity selection were carried out in the same way, except that 1:200 and 1:400 sera dilution was added to 100μl of diluted phages from the last round.</Brief_Description>
<BiopanningDataSet_Comments>In the screening phase, 19 out of 20 randomly selected phage clones exhibited specific reaction with purified sera IgG from early primary HCC patients, among them 14 coming from the same phage clone with inserted peptide sequence RGWCRPLPKGEG (named HC1). The HC1 mimic peptide showed high diagnostic validity for early primary HCC, and thereby could be a candidate serum biomarker for early primary HCC.</BiopanningDataSet_Comments>
</Item><Item><BiopanningDataSetID>1892</BiopanningDataSetID>
<Peptides>KMSNSIY
KLWVIPQ
KLYTPVD</Peptides>
<Motif></Motif>
<Unique_Sequence_Number>3</Unique_Sequence_Number>
<Experimental_Method>Phage display (subtractive panning)</Experimental_Method>
<Rounds_of_Panning>4</Rounds_of_Panning>
<Reference>PMID:22092230</Reference>
<Target_Name>Human chronic myeloid leukemia (CML) cell lines KT-1/A3</Target_Name>
<Template_Name>Not determined.</Template_Name>
<Structure_of_Target_Template_Complex>Not determined.</Structure_of_Target_Template_Complex>
<Structure_of_Target_Peptide_Complex>Not determined.</Structure_of_Target_Peptide_Complex>
<Library_Name>Ph.D.-7 phage display library (X7)</Library_Name>
<Affinity_Measurement_Method></Affinity_Measurement_Method>
<Affinity_Measurement_Description></Affinity_Measurement_Description>
<Brief_Description>IFN-a-sensitive KT-1/A3 cells were used as the target, and IFN-a-resistant subline KT-1/A3R was used as absorber for phage display biopanning.</Brief_Description>
<BiopanningDataSet_Comments>Totally, 210 phage clones were picked for screening whole-cell ELISA, among which six phages were differently reactive against KT-1/A3 and KT-1/A3R cells. Multiple clones showed high binding efficiency to KT-1/A3 cells compared with that of the other leukemia cells. One of the peptides, KLWVIPQ, has a partial amino acid sequence homology with the C-terminal domain of E3 ubiquitin-protein ligase.</BiopanningDataSet_Comments>
</Item><Item><BiopanningDataSetID>1893</BiopanningDataSetID>
<Peptides>TFLPQPRCSALLRYLSEDGVIVPS</Peptides>
<Motif></Motif>
<Unique_Sequence_Number>1</Unique_Sequence_Number>
<Experimental_Method>Phage display (common panning)</Experimental_Method>
<Rounds_of_Panning>4</Rounds_of_Panning>
<Reference>PMID:10411639</Reference>
<Target_Name>Urease</Target_Name>
<Template_Name>Not determined.</Template_Name>
<Structure_of_Target_Template_Complex>Not determined.</Structure_of_Target_Template_Complex>
<Structure_of_Target_Peptide_Complex>Not determined.</Structure_of_Target_Peptide_Complex>
<Library_Name>X10-ALLRY-X10 phage display library</Library_Name>
<Affinity_Measurement_Method>ELISA,Competition experiment</Affinity_Measurement_Method>
<Affinity_Measurement_Description>The absorbance was measured at 450 nm (data not shown). About 60% of the clones selected from the combinatorial library gave a positive ELISA signal. The 24-mer peptide inhibits the activity of H. pylori urease holoenzyme in a competitive manner. The calculated inhibition constant (Ki) was 49 μm.</Affinity_Measurement_Description>
<Brief_Description></Brief_Description>
<BiopanningDataSet_Comments>The same 24-amino-acid peptide sequence (TFLPQPRCSALLRYLSEDGVIVPS) was found in all of the 10 phage clones isolated from the combinatorial library.</BiopanningDataSet_Comments>
</Item><Item><BiopanningDataSetID>1894</BiopanningDataSetID>
<Peptides>YDFYWW</Peptides>
<Motif></Motif>
<Unique_Sequence_Number>1</Unique_Sequence_Number>
<Experimental_Method>Phage display (common panning)</Experimental_Method>
<Rounds_of_Panning>4</Rounds_of_Panning>
<Reference>PMID:10411639</Reference>
<Target_Name>Urease</Target_Name>
<Template_Name>Not determined.</Template_Name>
<Structure_of_Target_Template_Complex>Not determined.</Structure_of_Target_Template_Complex>
<Structure_of_Target_Peptide_Complex>Not determined.</Structure_of_Target_Peptide_Complex>
<Library_Name>X6 fdMED1 phage display library</Library_Name>
<Affinity_Measurement_Method>ELISA,Competition experiment</Affinity_Measurement_Method>
<Affinity_Measurement_Description>The absorbance was measured at 450 nm (data not shown).  About 20% of the clones selected from the unconstrained hexapeptide library gave a positive ELISA signal. The hexapeptide inhibits urease activity in an uncompetitive manner and the calculated inhibition constant (Ki) was 30 μm.</Affinity_Measurement_Description>
<Brief_Description></Brief_Description>
<BiopanningDataSet_Comments>The same six-amino-acid peptide sequence (YDFYWW) in the 10 clones were selected from the unconstrained library.</BiopanningDataSet_Comments>
</Item><Item><BiopanningDataSetID>1895</BiopanningDataSetID>
<Peptides>CQSPSLQC
CVFQNLDC
CKDGGNAC</Peptides>
<Motif></Motif>
<Unique_Sequence_Number>3</Unique_Sequence_Number>
<Experimental_Method>Phage display (common panning)</Experimental_Method>
<Rounds_of_Panning>4</Rounds_of_Panning>
<Reference>PMID:10411639</Reference>
<Target_Name>Urease</Target_Name>
<Template_Name>Not determined.</Template_Name>
<Structure_of_Target_Template_Complex>Not determined.</Structure_of_Target_Template_Complex>
<Structure_of_Target_Peptide_Complex>Not determined.</Structure_of_Target_Peptide_Complex>
<Library_Name>CX6C fdMED1 phage display library</Library_Name>
<Affinity_Measurement_Method></Affinity_Measurement_Method>
<Affinity_Measurement_Description></Affinity_Measurement_Description>
<Brief_Description></Brief_Description>
<BiopanningDataSet_Comments></BiopanningDataSet_Comments>
</Item><Item><BiopanningDataSetID>1896</BiopanningDataSetID>
<Peptides>CRLKEKHC(10)</Peptides>
<Motif></Motif>
<Unique_Sequence_Number>1</Unique_Sequence_Number>
<Experimental_Method>Phage display (common panning)</Experimental_Method>
<Rounds_of_Panning>3</Rounds_of_Panning>
<Reference>PMID:22100634</Reference>
<Target_Name>Anti-CD11b monoclonal antibody 44a</Target_Name>
<Template_Name>Integrin alpha-M, integrin αM</Template_Name>
<Structure_of_Target_Template_Complex>Not determined.</Structure_of_Target_Template_Complex>
<Structure_of_Target_Peptide_Complex>Not determined.</Structure_of_Target_Peptide_Complex>
<Library_Name>CX6C fdMED1 phage display library</Library_Name>
<Affinity_Measurement_Method></Affinity_Measurement_Method>
<Affinity_Measurement_Description></Affinity_Measurement_Description>
<Brief_Description></Brief_Description>
<BiopanningDataSet_Comments>Independent phage clones (94 bacterial clones) from the third round of selection were grown individually and their phage retested for binding to mAb 44a (IgG 2a) and to murine irrelevant IgG2a. Sixty-two pIII-cys-6aa-cys clones bound, specifically to mAb 44a, but not by no reactivity with isotype control was observed. The DNA inserts of the 10 phage clones giving the strongest ELISA signals were sequenced, and their amino acid sequences were deduced. One peptide sequence C-RLKEKH-C (frequency=10/10) which appears to be responsible for the specific binding to mAb 44a was identified. The selected peptide mimics a discontinuous epitope, a peculiar shape on the CD11b-I-domain surface. Competitive ELISA experiments with different Mac-1 ligands showed that C-RLKEKH-C is able to bind to fibrinogen, iC3b, and C1q.</BiopanningDataSet_Comments>
</Item><Item><BiopanningDataSetID>1897</BiopanningDataSetID>
<Peptides>YTSPHHSTTGHL
SMMLPFPHQPNA
AVPHRVGGLHSL</Peptides>
<Motif></Motif>
<Unique_Sequence_Number>3</Unique_Sequence_Number>
<Experimental_Method>Phage display (subtractive panning)</Experimental_Method>
<Rounds_of_Panning>4</Rounds_of_Panning>
<Reference>PMID:22107959</Reference>
<Target_Name>MBP mouse Kelch protein (MBP-Kelch)</Target_Name>
<Template_Name>Nuclear factor erythroid 2-related factor 2</Template_Name>
<Structure_of_Target_Template_Complex>1X2R,2DYH,</Structure_of_Target_Template_Complex>
<Structure_of_Target_Peptide_Complex>Not determined.</Structure_of_Target_Peptide_Complex>
<Library_Name>Ph.D.-12 phage display library (X12)</Library_Name>
<Affinity_Measurement_Method></Affinity_Measurement_Method>
<Affinity_Measurement_Description></Affinity_Measurement_Description>
<Brief_Description>In forth round, the bound phage were eluted with ETGE peptide. MBP and MBP-Kelch(G364C) were used to carry out subtractive screening.</Brief_Description>
<BiopanningDataSet_Comments></BiopanningDataSet_Comments>
</Item><Item><BiopanningDataSetID>1898</BiopanningDataSetID>
<Peptides>GSSTGPQRLHVP</Peptides>
<Motif></Motif>
<Unique_Sequence_Number>1</Unique_Sequence_Number>
<Experimental_Method>Phage display (subtractive panning)</Experimental_Method>
<Rounds_of_Panning>4</Rounds_of_Panning>
<Reference>PMID:22107959</Reference>
<Target_Name>MBP mouse Kelch protein (MBP-Kelch)</Target_Name>
<Template_Name>Nuclear factor erythroid 2-related factor 2</Template_Name>
<Structure_of_Target_Template_Complex>1X2R,2DYH,</Structure_of_Target_Template_Complex>
<Structure_of_Target_Peptide_Complex>Not determined.</Structure_of_Target_Peptide_Complex>
<Library_Name>Ph.D.-12 phage display library (X12)</Library_Name>
<Affinity_Measurement_Method></Affinity_Measurement_Method>
<Affinity_Measurement_Description></Affinity_Measurement_Description>
<Brief_Description>In forth round, the bound phage were eluted with ETGE peptide. MBP and MBP-Kelch(G430C) were used to carry out subtractive screening.</Brief_Description>
<BiopanningDataSet_Comments></BiopanningDataSet_Comments>
</Item><Item><BiopanningDataSetID>1899</BiopanningDataSetID>
<Peptides>NTMHYTGHTHSP
HAKSQLNPPDIK
GSSTGPQRLHVP
TLDLPGWTIVSH</Peptides>
<Motif></Motif>
<Unique_Sequence_Number>4</Unique_Sequence_Number>
<Experimental_Method>Phage display (subtractive panning)</Experimental_Method>
<Rounds_of_Panning>4</Rounds_of_Panning>
<Reference>PMID:22107959</Reference>
<Target_Name>MBP mouse Kelch protein (MBP-Kelch)</Target_Name>
<Template_Name>Nuclear factor erythroid 2-related factor 2</Template_Name>
<Structure_of_Target_Template_Complex>1X2R,2DYH,</Structure_of_Target_Template_Complex>
<Structure_of_Target_Peptide_Complex>Not determined.</Structure_of_Target_Peptide_Complex>
<Library_Name>Ph.D.-12 phage display library (X12)</Library_Name>
<Affinity_Measurement_Method></Affinity_Measurement_Method>
<Affinity_Measurement_Description></Affinity_Measurement_Description>
<Brief_Description>In forth round, MBP and MBP-Kelch(G364C) were used to carry out subtractive screening.</Brief_Description>
<BiopanningDataSet_Comments></BiopanningDataSet_Comments>
</Item><Item><BiopanningDataSetID>1900</BiopanningDataSetID>
<Peptides>NTMHYTGHTHSP
SPNFSWLPLGTT
SILSTMSPHGAT
TPKNLPPPGQRA
HLPTHVRTIVGL
SYINNTPVVDRR</Peptides>
<Motif></Motif>
<Unique_Sequence_Number>6</Unique_Sequence_Number>
<Experimental_Method>Phage display (subtractive panning)</Experimental_Method>
<Rounds_of_Panning>4</Rounds_of_Panning>
<Reference>PMID:22107959</Reference>
<Target_Name>MBP mouse Kelch protein (MBP-Kelch)</Target_Name>
<Template_Name>Nuclear factor erythroid 2-related factor 2</Template_Name>
<Structure_of_Target_Template_Complex>1X2R,2DYH,</Structure_of_Target_Template_Complex>
<Structure_of_Target_Peptide_Complex>Not determined.</Structure_of_Target_Peptide_Complex>
<Library_Name>Ph.D.-12 phage display library (X12)</Library_Name>
<Affinity_Measurement_Method></Affinity_Measurement_Method>
<Affinity_Measurement_Description></Affinity_Measurement_Description>
<Brief_Description>In forth round, MBP and MBP-Kelch(G430C) were used to carry out subtractive screening.</Brief_Description>
<BiopanningDataSet_Comments></BiopanningDataSet_Comments>
</Item></BiopanningDataSet></result>